Explore EATRIS as a companya patienta scientista policy-makera visitor Login
Visit of EATRIS C&S delegates to EATRIS Bulgaria
Call open for IMIBIC-P2Med Fellowships
Launch TRANSMED Academy: EATRIS e-learning platform for translational research
Webinar Series on Quality and Reproducibility issues in drug development
EATRIS’ flagship project for sustainability and personalised medicine (EATRIS-Plus) granted by the European Commission
Apply until 30 September: Executive Masters in Management of Research Infrastructures
Participants’ feedback for our Annual Meeting 2018 in Ljubljiana, Slovenia
Optimise cell therapies in solid tumours: The need for a multimodal imaging platform
EFPIA, EATRIS, ELIXIR, BBMRI, ECRIN statement on the role of research infrastructures to boost patient-centred research and innovation in Europe
The European Patients’ Forum and EATRIS sign collaboration agreement
Ring testing report on repeatability and reproducibility of small animal MRI systems
EATRIS appointed its new Scientific Advisory Board
EATRIS Annual Report 2018
14 institutions to form the Portuguese Node
Online training needs survey for research in rare diseases
Global Experts Define Characteristics of Successful Translational Scientists
EATRIS discuss Imaging and Cell Therapies at the Advanced Therapies and Regenerative Medicine Congress in London
Personalized Medicine Coalition elects Dr. Toni Andreu as member of the Board of Directors